Partnership with AstraZeneca

We are pleased to announce our partnership with AstraZeneca

intellin^®

understand your risk of complications

Simplify the management of diabetes and see if you are at risk of developing future complications.

Connect

over 150 apps & devices

Connect to over 150 apps & devices. Made by major brands such as Fitbit, Garmin, iHealth, Polar, Suunto, Omron, Withings and more.

Our Vision

Artificial Intelligence to measure and improve outcomes for patients with diabetes.

Our solutions are made in collaboration with patients and healthcare professionals, so that we truly understand their needs. We then use our experience from the Pharmaceutical Industry to test our solutions so that we know they can help improve outcomes.

Evidence based

Intellin takes the holistic approach to the individual with diabetes, it merges the individual's data with the latest research and recommendations to provide meaningful information. This information is used to support the individual to develop their own holistic personalised care plan. This app is not just about data entering and storage of information, it assists with the interpretation. I personally have already encouraged friends and family members to start using this app to support them in their diabetes journey.

— Dr Natasha H Patel

Consultant Diabetologist at Guy’s & St Thomas’ in London

Feet are incredible, they are our foundation and yet they are so often neglected. They often mirror our general health so it’s vital that you can recognise problems early and not ignore them. These simple tips and advice will help you to implement a regular foot care regime so you can take positive actions towards your foot health.

— Dr Judith Anders

Podiatrist

www.feelyourfeet.com

Helping to achieve, give encouragement and reason for safe exercise goals and ultimately lifestyle change for best management of diabetes.

— Jacqui Moran

BSc (Hons) PG Dip RD Sports Nutritionist SP

The dietary tips and advice provided are based on the latest evidence base for the prevention and management of Diabetes and are designed to help you to make simple and effective changes to improve your health.

— Anne Myers-Wright

RD/APD

www.amdietetics.com

Introducing intellin^®

Patients

Intellin^® is a new type of platform that helps you live with diabetes. For the first time, you can have a personalised assistant that helps you make good decisions, every day, about how best to decrease the risk of complications from your diabetes.

It will allow you to track your diabetes, but also help you make good decisions every day to help you reduce the risk of your diabetes getting worse
Intellin^® can now connect to over 150 apps & devices, such as: blood glucose monitors, blood pressure monitors, fitness trackers. We’re working on connecting Intellin^® to your other healthcare tools including Apple Health and fitness apps.
If you want to, you can share your information with friends or family - or your healthcare professional
Everything you see on Intellin has been reviewed and ‘signed off’ by our Clinical Team, so you can be sure that it is accurate

Healthcare Professionals

Intellin^® is an advance on the current range of diabetes ‘apps’. It goes into far more of the clinical history of your patient and generates a ‘risk profile’ indicating when disease progression is most likely to occur – be it risk of foot ulcer, kidney damage or other consequences of diabetes.

The risk profile engine has been developed in conjunction with Nottingham University, and validated by our Clinical Team
Intellin^® has been tested in two proof of concept studies in Gestational Diabetes through a grant won from SBRI Northern Ireland and is currently being used in the INDUCE study to look at the reduction of diabetic foot ulcers at Salford Royal Hospital NHS Foundation Trust
Additionally, there is functionality to provide you with a dashboard of key indicators on either individual or cohorts of patients which could allow you to ‘triage’ calls to clinic

Payors and Insurers

Intellin® has the potential to take costs out of the system by empowering people with diabetes to take control of their diabetes and better self-manage.

A cost effective, easily accessible solution, Intellin® is analogous to a ‘black box’ that is used by car insurance companies. By tracking how someone drives, accident risk is reduced. Intellin® brings this principle to the clinical setting. Good daily management can potentially reduce downstream risk and generate considerable savings
Within the NHS, Intellin® fulfils the vision of the 5 year plan by providing appropriate, validated digital technology
For every 1% reduction in HbA1c, there is a relative risk reduction of 21% for any diabetes-related endpoint, 21% for diabetes-related death, and 37% for microvascular complication^*.

*Stratton I. M., Adler A. I., Neil H. A. et al (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ, Volume 321(7,258): 405-12.

Partnership with AstraZeneca

Evidence based

— Dr Natasha H Patel

— Dr Judith Anders

— Jacqui Moran

— Anne Myers-Wright

Introducing intellin®

Patients

It will allow you to track your diabetes, but also help you make good decisions every day to help you reduce the risk of your diabetes getting worse

Intellin® can now connect to over 150 apps & devices, such as: blood glucose monitors, blood pressure monitors, fitness trackers. We’re working on connecting Intellin® to your other healthcare tools including Apple Health and fitness apps.

If you want to, you can share your information with friends or family - or your healthcare professional

Everything you see on Intellin has been reviewed and ‘signed off’ by our Clinical Team, so you can be sure that it is accurate

Healthcare Professionals

The risk profile engine has been developed in conjunction with Nottingham University, and validated by our Clinical Team

Intellin® has been tested in two proof of concept studies in Gestational Diabetes through a grant won from SBRI Northern Ireland and is currently being used in the INDUCE study to look at the reduction of diabetic foot ulcers at Salford Royal Hospital NHS Foundation Trust

Additionally, there is functionality to provide you with a dashboard of key indicators on either individual or cohorts of patients which could allow you to ‘triage’ calls to clinic

Payors and Insurers

Within the NHS, Intellin® fulfils the vision of the 5 year plan by providing appropriate, validated digital technology

For every 1% reduction in HbA1c, there is a relative risk reduction of 21% for any diabetes-related endpoint, 21% for diabetes-related death, and 37% for microvascular complication*.

Introducing intellin^®

Intellin^® can now connect to over 150 apps & devices, such as: blood glucose monitors, blood pressure monitors, fitness trackers. We’re working on connecting Intellin^® to your other healthcare tools including Apple Health and fitness apps.

Intellin^® has been tested in two proof of concept studies in Gestational Diabetes through a grant won from SBRI Northern Ireland and is currently being used in the INDUCE study to look at the reduction of diabetic foot ulcers at Salford Royal Hospital NHS Foundation Trust

For every 1% reduction in HbA1c, there is a relative risk reduction of 21% for any diabetes-related endpoint, 21% for diabetes-related death, and 37% for microvascular complication^*.